Fingerprint
Dive into the research topics of 'Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Adjuvant high-dose interferon for cutaneous melanoma is most beneficial for patients with early stage III disease
Daniel A. Anaya, Yan Xing, Lei Feng, Xuelin Huang, Luis H. Camacho, Merrick I. Ross, Jeffrey E. Gershenwald, Jeffrey E. Lee, Paul F. Mansfield, Janice N. Cormier
Research output: Contribution to journal › Article › peer-review
18
Scopus
citations